Is Aeterna Zentaris Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: AEZS) stock is to Buy AEZS stock.
Out of 1 analyst, 0 (0%) are recommending AEZS as a Strong Buy, 1 (100%) are recommending AEZS as a Buy, 0 (0%) are recommending AEZS as a Hold, 0 (0%) are recommending AEZS as a Sell, and 0 (0%) are recommending AEZS as a Strong Sell.
What is AEZS's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: AEZS) forecast ROE is -48.86%, which is considered weak.
What is AEZS's Price Target?
According to 1 Wall Street analyst that have issued a 1 year AEZS price target, the average AEZS price target is $28.00, with the highest AEZS stock price forecast at $28.00 and the lowest AEZS stock price forecast at $28.00.
The Wall Street analyst predicted that Aeterna Zentaris's share price could reach $28.00 by May 12, 2024. The average Aeterna Zentaris stock price prediction forecasts a potential upside of 918.55% from the current AEZS share price of $2.75.
What is AEZS's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: AEZS) forecast ROA is -29.73%, which is lower than the forecast US Biotechnology industry average of -9.47%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.